We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
AusPAR: RINVOQ
Australian Public Assessment Report
Device/Product Name
Rinvoq
Active ingredients
Upadacitinib
AusPAR Date
Published
Sponsor
Submission Number
PM-2020-04791-1-1
Submission Type
Extension of indications and major variation (new strength)
Decision
Approved